|
Synonyms: compound of formula (I) [1] | UCB-6492
Compound class:
Synthetic organic
Comment: UCB6492 is an orally bioavailable small-molecule IL-17A inhibitor [1]. The structure was first disclosed during the European Federation for Medicinal Chemistry and Chemical Biology's International Symposium on Medicinal Chemistry (EFMC-ISMC) in 2026. The compound is proposed for the treatment of IL-17A-mediated inflammatory and autoimmune disorders.
|
|
|||||||||||||||||
| References |
|
1. Bruffaerts J, Haslett GW. (2024)
Imidazotriazine derivatives as il-17 modulators. Patent number: WO2024218032A1. Assignee: UCB Biopharma SRL. Priority date: 15/04/2024. Publication date: 24/10/2024. |